Pediatrix Medical
332 hedge funds and large institutions have $5.73B invested in Pediatrix Medical in 2017 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 118 increasing their positions, 128 reducing their positions, and 53 closing their positions.
45% more call options, than puts
Call options by funds: $5.56M | Put options by funds: $3.84M
8% less repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 128
5.89% less ownership
Funds ownership: 107.95% → 102.06% (-5.9%)
8% less funds holding
Funds holding: 359 → 332 (-27)
18% less capital invested
Capital invested by funds: $6.96B → $5.73B (-$1.22B)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
49% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 53
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$144M |
| 2 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$63M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$62.1M |
| 4 |
HM
HealthCor Management
New York
|
+$55.9M |
| 5 |
FMI
Fiduciary Management Inc
Milwaukee,
Wisconsin
|
+$34.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$133M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$105M |
| 3 |
Ninety One (UK)
London,
United Kingdom
|
-$80.1M |
| 4 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$65.1M |
| 5 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$46.5M |
MD Hedge Fund Activity: Q2 2017 in Review
332 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2017, worth a combined $5.73B — down 18% from $6.96B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of MD and 27 opened new positions — a net loss of 26 holders — while 128 trimmed existing stakes and 118 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $144M. The largest seller was Fidelity Investments, cutting an estimated $133M.
- 332 institutional investors held Pediatrix Medical (MD) as of Q2 2017, down from 359 in Q1 2017.
- Funds reported $5.73B of Pediatrix Medical stock for Q2 2017, down 18% quarter-over-quarter.
- 27 funds opened new Pediatrix Medical positions in Q2 2017 and 53 closed out, a net change of -26 holders.
- The largest Pediatrix Medical buyer in Q2 2017 was T. Rowe Price Associates, an estimated $144M added.
- The largest Pediatrix Medical seller in Q2 2017 was Fidelity Investments, an estimated $133M sold.
Based on aggregated 13F filings for Q2 2017.